卵泡抑素对肿瘤恶病质小鼠骨骼肌消耗的影响及其作用机制

doi:10.13481/j.1671-587x.20160404

Abstract

Abstract:

Objective: To observe the effects of follistatin(FST) on the skeletal muscle wasting of cancer cachexia mice and the expressions of Mstn,LncRNA-MALAT1 and Caspase-3,and to elucidate its associated molecular mechanisms. Methods: Thirty-two BALB/c mices were randomly assigned into:healthy control (HC) group,FST prevention (FP) group,FST treatment (FT) group and cancer cachexia(CC) group.The murine colon adenocarcinoma CT26 cells were inoculated subcutaneously into the mices in FP,FT and CC groups to establish the cancer cachexia models.The body weight,spontaneous activity and tumor growth were daily monitored.The mice in FP and FT groups were administrated with FST intraperitoneally on day 6 and 12 after inoculation.The samples were collected on day 20. The tumor and gastrocnemius weights of the mice were detected.The biochemical metabolism indexes and myofiber cross-sectional area of gastrocnemius tissue were detected. The mRNA expression levels of Mstn,Caspase-3 and LncRNA-MALAT1 were examined by Real-time PCR. The protein expression levels of Mstn and Caspase-3 were measured by Western blotting method. Results: Compared with CC group,the body weights,spontaneous activities,gastrocnemius weights and myofiber cross-sectional areas were increased(P < 0.05); the serum levels of glucose,total protein and albumin of the mice in FP and FT groups were increased (P < 0.05). The protein and mRNA expression levels of Mstn and Caspase-3 in gastrocnemius of the mice in CC group were significantly higher and the expression level of LncRNA-MALAT1 was significantly lower than those in HC group(P < 0.05).The mRNA and protein expression levels of Mstn and Caspase-3 in FP and FT groups were reduced and the expression level of LncRNA-MALAT1 was increased compared with CC group(P < 0.05).The prevention effect in FP group is better than FT group(P < 0.05). Conclusion: FST may alleviate the muscle wasting of the mice with cancer cachexia by inhibiting the expression of Mstn,thus upregulating the expression of LncRNA-MALAT1 which in turn to suppress the expression of Caspase-3.

Key words: cancer cachexia, follistatin, myostatin, long non-coding RNA, metastasis-associated lung adenocarcinoma transcript1

CLC Number:

R730.5

WANG Chaoyi, WANG Qiang, ZHENG Yueyong, LI Cong, GUO Dunwei, TANG Hua. Effect of follistatin on skeletal muscle wasting of cancer cachexia mice and its mechanism[J].Journal of Jilin University Medicine Edition, 2016, 42(04): 653-658.

References

[1] Fearon K,Strasser F,Anker SD,et al.Definition and classification of cancer cachexia:an international consensus[J].Lancet Oncol,2011,12(5):489-495.

[2] Tisdale MJ. Cancer cachexia[J]. Anticancer Drugs,1993,4(2):115-125.

[3] 薛鹏,陶钧,赵晖,等.Myostatin基因在荷瘤裸鼠腓肠肌组织中的表达[J].上海交通大学学报:医学版,2006,26(10):1143-1146.

[4] Gallot YS,Durieux AC,Castells J,et al. Myostatin gene inactivation prevents skeletal muscle wasting in cancer[J]. Cancer Res,2014,74(24):7344-7356.

[5] Thissen JP,Loumaye A. Role of Activin A and Myostatin in cancer cachexia[J]. Ann Endocrinol (Paris),2013,74(2):79-81.

[6] Watts R,Johnsen VL,Shearer J,et al. Myostatin-induced inhibition of the long noncoding RNA Malat1 is associated with decreased myogenesis[J]. Am J Physiol Cell Physiol,2013,304(10):C995-1001.

[7] Guo F,Li Y,Liu Y,et al. Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion[J]. Acta Biochim Biophys Sin (Shanghai),2010,42(3):224-229.

[8] Du J,Wang X,Miereles C,et al. Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions[J]. J Clin Invest,2004,113(1):115-123.

[9] Lee SJ,Lee YS,Zimmers TA,et al. Regulation of muscle mass by follistatin and activins[J]. Mol Endocrinol,2010,24(10):1998-2008.

[10] Aulino P,Berardi E,Cardillo VM,et al. Molecular,cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse[J]. BMC Cancer,2010,10:363.

[11] Han HQ,Mitch WE. Targeting the myostatin signaling pathway to treat muscle wasting diseases[J]. Curr Opin Support Palliat Care,2011,5(4):334-341.

[12] Ji P,Diederichs S,Wang W,et al. MALAT-1,a novel noncoding RNA,and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer[J]. Oncogene,2003,22(39):8031-8041.

[13] Tripathi V,Ellis JD,Shen Z,et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation[J]. Mol Cell,2010,39(6):925-938.

[14] Änkö ML,Müller-McNicoll M,Brandl H,et al. The RNA-binding landscapes of two SR proteins reveal unique functions and binding to diverse RNA classes[J]. Genome Biol,2012,13(3):R17.

[15] Han X,Yang F,Cao H,et al. Malat1 regulates serum response factor through miR-133 as a competing endogenous RNA in myogenesis[J]. FASEB J,2015,29(7):3054-3064.

[16] Iizuka K,Machida T,Hirafuji M.Skeletal muscle is an endocrine organ[J]. J Pharmacol Sci,2014,125(2):125-131.

Effect of follistatin on skeletal muscle wasting of cancer cachexia mice and its mechanism

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 3

Metrics

Comments

Recommended 10

[1]	ZHENG Yue-yong,LIU Hong,LI Cong,WANG Qiang,TANG Hua. Effect of Caspase-3 in skeletal muscle protein consumption of cancer cachexia mice [J]. Journal of Jilin University Medicine Edition, 2014, 40(04): 710-714.
[2]	YUAN Ting,LIU Shuai,LI Xiao-ping,TANG Cheng-cheng,HAN Xiao-lei\|PANG Da-xin,OUYAN. Construction and identification of skeletal muscle-specific FS Ⅰ-Ⅰ expression transgenic porcine embryonic fibroblast lines [J]. J4, 2012, 38(2): 192-196.
[3]	ZHANG Chen-hao,LIU Zhong-hui，LIU Hai-yan,WANG Yi-nan,GE Jing-yan,YU Fang,TAI Gui-xiang. Expressions of activin A and its binding protein follistatin in pancreatic tissues of streptozotocin-induced diabetic mice and their significances [J]. J4, 2009, 35(2): 292-295.